Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?

Literature DB >> 20682514

Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?

Abstract

Liver biopsy has been used to diagnose chronic liver disease and to assess the degree of hepatic inflammation and fibrosis. However, it is an invasive test with many possible complications and the potential for sampling error. Noninvasive tests are increasingly precise in identifying the cause of many cases of liver disease and even the amount of liver injury (fibrosis). This review discusses the role of noninvasive tests to diagnose liver disease and to assess hepatic fibrosis and cirrhosis.

Entities: Disease

Mesh：

Substances：
Biomarkers

Year: 2010 PMID： 20682514 DOI： 10.3949/ccjm.77a.09138

Source DB: PubMed Journal: Cleve Clin J Med ISSN： 0891-1150 Impact factor: 2.321

Keyword Cloud
Cited

23 in total

1. Comparison of AI techniques for prediction of liver fibrosis in hepatitis patients.

Authors: Brian Keltch; Yuan Lin; Coskun Bayrak
Journal: J Med Syst Date: 2014-06-24 Impact factor: 4.460

2. Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosis.

Authors: Saurabh Sethi; Douglas A Simonetto; Soha S Abdelmoneim; Michael B Campion; Irakli Kaloiani; Amy C Clayton; Walter K Kremers; Kevin C Halling; Patrick S Kamath; Jayant Talwalkar; Vijay H Shah
Journal: J Clin Exp Hepatol Date: 2012-04-12

3. An analysis of intrinsic variations of low-frequency shear wave speed in a stochastic tissue model: the first application for staging liver fibrosis.

Authors: Yu Wang; Min Wang; Jingfeng Jiang
Journal: Phys Med Biol Date: 2017-02-07 Impact factor: 3.609

4. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis.

Authors: Rahul Rustogi; Jeanne Horowitz; Carla Harmath; Yi Wang; Hamid Chalian; Daniel R Ganger; Zongming E Chen; Bradley D Bolster; Saurabh Shah; Frank H Miller
Journal: J Magn Reson Imaging Date: 2012-01-13 Impact factor: 4.813

5. Evaluation of the utility of serum prolidase as a marker for liver fibrosis.

Authors: John C Stanfliet; Michael Locketz; Peter Berman; Tahir S Pillay
Journal: J Clin Lab Anal Date: 2014-05-05 Impact factor: 2.352

6. Quantification of liver fibrosis via second harmonic imaging of the Glisson's capsule from liver surface.

Authors: Shuoyu Xu; Chiang Huen Kang; Xiaoli Gou; Qiwen Peng; Jie Yan; Shuangmu Zhuo; Chee Leong Cheng; Yuting He; Yuzhan Kang; Wuzheng Xia; Peter T C So; Roy Welsch; Jagath C Rajapakse; Hanry Yu
Journal: J Biophotonics Date: 2015-07-01 Impact factor: 3.207

Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?

1. Comparison of AI techniques for prediction of liver fibrosis in hepatitis patients.

2. Comparison of circulating endothelial cell/platelet count ratio to aspartate transaminase/platelet ratio index for identifying patients with cirrhosis.

3. An analysis of intrinsic variations of low-frequency shear wave speed in a stochastic tissue model: the first application for staging liver fibrosis.

4. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis.

5. Evaluation of the utility of serum prolidase as a marker for liver fibrosis.

6. Quantification of liver fibrosis via second harmonic imaging of the Glisson's capsule from liver surface.

7. Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.

Review 8. Non-alcoholic fatty liver disease in 2015.

Review 9. Role of liver biopsy in the era of direct-acting antivirals.

10. Evaluation of Aspartate Aminotransferase-to-Platelet Ratio Index as a Non-Invasive Marker for Liver Cirrhosis.